Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Please provide your email address to receive an email when new articles are posted on . Two weeks of metoprolol improved left ventricular outflow tract gradients, symptoms and quality of life compared ...
A novel transcatheter mitral valve replacement system designed for left atrial fixation rather than subvalvular fixation ...
Dr. David M. Dudzinski: A 78-year-old man was evaluated in the cardiology clinic of this hospital because of biventricular myocardial wall thickening, progressive mitral regurgitation, and ventricular ...
The FDA on Friday approved aficamten (Myqorzo) for symptomatic obstructive hypertrophic cardiomyopathy (HCM), drugmaker Cytokinetics announced. Aficamten is an allosteric and reversible inhibitor of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results